Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 319, pseudogene (RN7SL319P) is a human pseudogene related to the 7SL RNA gene. The functional 7SL RNA is a core component of the signal recognition particle (SRP), which is essential for targeting secretory proteins to the endoplasmic reticulum[1][7]. In contrast, most RN7SL pseudogenes—including RN7SL319P—are unexpressed, non-functional genomic elements that arose via retrotransposition or genomic rearrangement, leading to loss of coding potential and biological function[4][5][8]. These pseudogenes do not encode any active protein or RNA product and are not considered therapeutic targets, receptors, enzymes, or druggable entities. There is no evidence implicating RN7SL319P in disease, nor are there any known drugs, biomarkers, or safety issues related to this pseudogene. Key points: - Not a therapeutic target: RN7SL319P lacks protein-coding or functional RNA capacity and does not participate in recognized biological roles or disease processes[5]. - Pseudogene: Classified as a non-functional genomic sequence (pseudogene) related to the parent 7SL RNA gene[5][4]. - No known biological, pathological, or pharmacological function: Pseudogenes like RN7SL319P are generally considered genomic relics with no direct functional impact[5]. Note: - The query describes a *non-functional pseudogene* rather than a valid receptor, enzyme, transporter, or other therapeutic target class. - This makes RN7SL319P inappropriate as a therapeutic target for most scientific or drug discovery purposes. - If information about the functional 7SL RNA (component of the SRP) is required, please specify, as 7SL RNA performs vital roles in protein targeting and cell biology[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 319, pseudogene (RN7SL319P).